Research to Prevent Blindness

March 28, 2023

Inflammation implicated in exfoliation syndrome

Computational genetics tools have implicated inflammatory pathways in exfoliation syndrome, the most common cause of secondary glaucoma, which can result in blindness.

By Leigh MacMillan
October 10, 2022

Opening a window to glaucoma

A metalloprotease enzyme plays an important role in retinal ganglion cell development, Vanderbilt researchers discovered; studying it and other family members may lead to the identification of novel targets for treating glaucoma.

By Bill Snyder
September 8, 2022

Calkins lands national award for research on blinding eye diseases

Vanderbilt’s David Calkins, PhD, has been selected by the Research to Prevent Blindness and Association of University Professors of Ophthalmology to receive the 2023 David F. Weeks Award for Outstanding Vision Research.

By Nancy Humphrey
August 15, 2022

Mitochondria and retinal degeneration

Vanderbilt researchers have developed a new cellular model for exploring mitochondrial dysfunction in age-related macular degeneration, the leading cause of blindness in people over 65.

By Leigh MacMillan
July 9, 2020

RPB grant to support research, treatment of blinding diseases

Research to Prevent Blindness (RPB) recently awarded a grant to investigators in Vanderbilt’s Department of Ophthalmology and Visual Sciences to support research into the causes, treatment and prevention of blinding diseases.

By Jessica Pasley
January 23, 2020

Insights on diabetic retinopathy

A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report.

By Leigh MacMillan
July 15, 2019

Potassium balance and glaucoma

Vanderbilt Eye Institute researchers have discovered that an imbalance in the ionic environment of retinal ganglion cells may contribute to functional impairments in glaucoma.
By Sanjay Mishra
July 1, 2019

Research to Prevent Blindness awards grants to Department of Ophthalmology

Vanderbilt Eye Institute receives grants to Research to study causes, treatment and prevention of blinding diseases.
By Jessica Pasley
November 8, 2018

Novel methods to treat glaucoma

Increasing a certain signaling molecule prevents the degeneration of retinal cells that are lost in glaucoma, suggesting a new way to treat this disease.
By VUMC News and Communications
June 28, 2018

Calkins lands innovation award from Research to Prevent Blindness

Jun. 28, 2018—David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has been granted one of the preeminent awards in vision research — the Research to Prevent Blindness (RPB) Stein Innovation Award.
By Jessica Pasley
July 21, 2016

Two receive Research to Prevent Blindness grants

Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology.
By Jessica Pasley
June 25, 2015

VEI receives grant from Research to Prevent Blindness for research and education

The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000.
By Jessica Pasley
December 16, 2014

Retinal neuron survival in glaucoma

Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.
By Leigh MacMillan